Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA)

被引:19
|
作者
Li, Xiao [1 ]
Xu, Feng [1 ]
He, Qi [1 ]
Wu, Lingyun [1 ]
Zhang, Zheng [1 ]
Chang, Chunkang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Hosp 6, Dept Hematol, Shanghai, Peoples R China
关键词
myelodysplastic syndromes; aplastic anemia; lymphocytes; T cell subsets; polarization; ANTITHYMOCYTE GLOBULIN; T-CELLS; PATHOPHYSIOLOGY; HEMATOPOIESIS; REPERTOIRE; MANAGEMENT;
D O I
10.2169/internalmedicine.49.3477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The subsets and the polarization of lymphocytes in bone marrow from low-risk myelodysplastic syndrome (MDS) were studied and compared with those from patients with aplastic anemia (AA). Methods A total of 34 patients with low-risk MDS (IPSS score <= 1.0) who presented abnormal chromosomes and 16 patients with AA were enrolled in this study. We determined T lymphocyte subsets, T cells polarization status, and the percentages of NK cells and of B lymphocytes in bone marrow and compared these parameters between the two groups of patients. As controls, 24 patients with high-risk MDS (IPSS score>1.0) presenting abnormal chromosomes and 22 healthy/benign hematologic disease subjects were used. Results In low-risk MDS/AA patients, the percentage of CD3+ lymphocytes was significantly increased compared to controls (p=0.006 and p=0.001), while the percentage of CD19+ lymphocytes was significantly decreased (p<0.001 and p=0.002); there were no significant differences between MDS/AA and normal controls in other parameters; For low-risk MDS patients, the polarization status of bone marrow CD4+ cells toward Th1 (Th1/Th2) and of CD8+ cells toward Tc1 (Tc1/Tc2) was stronger than that for AA patients (p=0.05 and p<0.001). Other parameters did not show significant differences; Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/Tc2). Conclusion In both AA and MDS, the number of total T lymphocytes increased. However, polarization towards Th1 and Tc1 was obviously stronger in MDS patients than in AA patients. This might be related to T cell stimulation from the clones of malignant hematopoietic cells.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 50 条
  • [21] Heterogeneous expressions of glycosylphosphatidylinositol (GPI)-anchored proteins by granulocytes and monocytes from patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS).
    Noji, H
    Okamoto, M
    Andoh, S
    Ikeda, K
    Maruyama, Y
    Shichishima, T
    BLOOD, 2003, 102 (11) : 329B - 329B
  • [22] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    Di Nardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 945 - 946
  • [23] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    DiNardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 945 - 946
  • [24] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    LABORATORY INVESTIGATION, 2005, 85 : 223A - 224A
  • [25] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    MODERN PATHOLOGY, 2005, 18 : 223A - 224A
  • [26] Updated Results of Combination Cytokine Immunotherapy In the Treatment of Aplastic Anemia and Myelodysplastic Syndrome (MDS)
    Kadia, Tapan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Estrov, Zeev
    Pierce, Sherry A.
    York, Sergernne
    Kantarjian, Hagop M.
    BLOOD, 2010, 116 (21) : 1202 - 1203
  • [27] Morphological, Immunohistochemical and Cytogenetic Bone Marrow Characterization of 12 Patients with Acquired Aplastic Anemia (AAA) That Progressed to Myelodysplastic Syndromes (MDS)
    Marchesi, Raquel
    Velloso, Elvira
    Garanito, Marlene
    Siqueira, Sheila
    Neto, Raymundo Azevedo
    Kumeda, Cristina
    Zerbini, Maria Claudia
    MODERN PATHOLOGY, 2017, 30 : 362A - 362A
  • [28] Morphological, Immunohistochemical and Cytogenetic Bone Marrow Characterization of 12 Patients with Acquired Aplastic Anemia (AAA) That Progressed to Myelodysplastic Syndromes (MDS)
    Marchesi, Raquel
    Velloso, Elvira
    Garanito, Marlene
    Siqueira, Sheila
    Neto, Raymundo Azevedo
    Kumeda, Cristina
    Zerbini, Maria Claudia
    LABORATORY INVESTIGATION, 2017, 97 : 362A - 362A
  • [29] IMMUNOHISTOLOGICAL ANALYSIS OF BONE-MARROW LYMPHOCYTES IN APLASTIC-ANEMIA
    FRICKHOFEN, N
    KIEM, HP
    RAGHAVACHAR, A
    HEIMPEL, H
    BLUT, 1987, 55 (04): : 220 - 220
  • [30] APLASTIC-ANEMIA, BONE-MARROW TRANSPLANTATION AND REPRESSOR LYMPHOCYTES
    ROSENSTRAUCH, WJCJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1977, 51 (12): : 363 - 364